101. Recommendations and management of hyperglycaemia in pregnancy during COVID-19 pandemic in Italy.
- Author
-
Torlone E, Sculli MA, Bonomo M, Di Benedetto A, Di Cianni G, Festa C, Formoso G, Lapolla A, Mannino D, Napoli A, Scavini M, Succurro E, Vitacolonna E, and Sciacca L
- Subjects
- Blood Glucose analysis, COVID-19, Coronavirus Infections complications, Coronavirus Infections epidemiology, Coronavirus Infections virology, Diabetes, Gestational physiopathology, Diabetes, Gestational virology, Disease Management, Female, Humans, Hyperglycemia epidemiology, Hyperglycemia virology, Hypoglycemic Agents therapeutic use, Italy epidemiology, Pneumonia, Viral complications, Pneumonia, Viral epidemiology, Pneumonia, Viral virology, Pregnancy, Pregnancy Complications, Infectious epidemiology, Pregnancy Complications, Infectious virology, SARS-CoV-2, Telemedicine methods, Betacoronavirus isolation & purification, Coronavirus Infections prevention & control, Diabetes, Gestational drug therapy, Hyperglycemia prevention & control, Insulin therapeutic use, Pandemics prevention & control, Pneumonia, Viral prevention & control, Practice Guidelines as Topic standards, Pregnancy Complications, Infectious prevention & control
- Abstract
Many specialists use the remote management of people with chronic disease as diabetes, but structured management protocols have not been developed yet. The COVID-19 pandemic has given a big boost to the use of telemedicine, as it allows to maintain the physical distance, essential to the containment of contagion having regular health contact. Encouraging results related to the use of telemedicine in women with hyperglycaemia in pregnancy, have been recently published. It is well known that hyperglycaemia alters the immune response to infections, that inflammation, in turn, worsens glycaemic control and that any form of hyperglycaemia in pregnancy (HIP) has effects not only on the mother but also on development of the foetus. Therefore, the Italian Diabetes and Pregnancy Study Group, together with a group of experts, developed these recommendations in order to guide physicians in the management of HIP, providing specific diagnostic, therapeutic and assistance pathways (PDTAs) for the COVID-19 emergency. Three detailed PDTAs were developed, for type 1, type 2 and gestational diabetes., Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF